Impactful New Science and Advancements in Cancer Care Research Revealed and Discussed at the US Oncology Research 17th Annual Science Forum

October 8, 2018

More than 200 leading cancer researchers gathered to discuss the future of cancer care THE WOODLANDS, TEXAS, October 8, 2018—US Oncology Research recently held its 17th Annual Science Forum (the Forum) in Denver, bringing together more than 200 leading research physicians and their clinical teams. This year’s agenda included a focus on leading-edge clinical and […]

Read More

The US Oncology Network Announces Top-Tier MIPS Results

October 4, 2018

Affiliated practices to benefit from high positive payment adjustment   THE WOODLANDS, TEXAS, October 4, 2018— The US Oncology Network (The Network) today announced results of the 2017 Merit-based Incentive Payment System (MIPS) for its affiliated practices. Based on the successful implementation of quality improvement, adoption and performance in the first year of MIPS, practices […]

Read More

US Oncology Research Joins Agendia’s FLEX Big Data Initiative, Accelerating Diagnostic Discoveries in Breast Cancer and Enabling Precision Oncology

August 23, 2018

Dataset of up to 10,000 full genome profiles matched with complete clinical data will provide representative resource for breast cancer research THE WOODLANDS, TEXAS, U.S., IRVINE, CALIF., U.S. and AMSTERDAM, NETHERLANDS (August 23, 2018) – Agendia, Inc., a world leader in precision oncology, announced today that US Oncology Research, one of the nation’s largest research […]

Read More

Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer

August 15, 2018

Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer US Oncology Research will open 10 clinical trial sites, enrolling patients in Novocure’s PANOVA-3 trial to test the efficacy of Tumor Treating Fields combined with nab-paclitaxel and gemcitabine in patients with unresectable locally advanced pancreatic cancer ST. HELIER, JERSEY, […]

Read More

Progressive Care Integrates with Illinois Cancer Specialists to Join The US Oncology Network

August 6, 2018

More patients in suburban Chicago will benefit from the combined expertise and resources Chicago, Illinois (August 6, 2018) – Illinois Cancer Specialists (ICS), an affiliate of The US Oncology Network (The Network), announced today that Progressive Care has joined its practice. The combined practice will continue to offer comprehensive, state-of-the-art cancer care in its nine […]

Read More

The US Oncology Network Promotes Leader in Value-Based Care Dr. Marcus Neubauer to Chief Medical Officer

July 17, 2018

Medical oncologist is appointed to spearhead The Network’s significant medical programs and collaborative, integrated approach to cancer care The Woodlands, Texas (July 17, 2018) —The US Oncology Network (The Network) announced the appointment of Marcus Neubauer, M.D., as its chief medical officer, building on its mission of delivering a comprehensive approach to cancer care. Michael […]

Read More

The US Oncology Network Welcomes Breast Surgeon Dr. Loren Rourke to a New Role as Chief Surgical Officer

July 9, 2018

Renowned breast surgeon appointed to spearhead The Network’s surgical programs and collaborative, integrated approach to cancer care The Woodlands, Texas (July 9, 2018) —The US Oncology Network (The Network) announced the appointment of Loren Rourke, M.D., M.H.C.M., as its chief surgical officer, a new role created to support and enhance the surgical community within The […]

Read More

Oncologists from The US Oncology Network and US Oncology Research to Present Data from More Than 40 Abstracts During the 54th Annual ASCO Meeting

May 30, 2018

Expansive clinical research and real-world evidence data to be presented on prostate cancer, genome sequencing, melanoma, bladder cancer, metastatic breast cancer and more The Woodlands, Texas (May 30, 2018) – McKesson Specialty Health announced today that oncologists from The US Oncology Network (The Network) and US Oncology Research will showcase detailed findings from 43 studies […]

Read More

Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma Drug

May 16, 2018

Study Wins the 2018 Clinical and Research Excellence (CARE) Award for Best in Health Economics and Outcomes The Woodlands, Texas (May 16, 2018) —  A powerful, real-world evidence study designed by McKesson Specialty Health for its biopharma partner played a key role in the Food and Drug Administration’s (FDA) approval for first-line indication for a […]

Read More

Texas Oncology Receives 2018 PBMI Excellence Award for Care Management Strategies

May 7, 2018

Industry Recognition Highlights Texas Oncology’s  Integrated Pharmacy Approach to Attain Better Patient Outcomes and Lower Costs DALLAS (May 7, 2018) — Texas Oncology, a practice in The US Oncology Network (The Network), received a 2018 Excellence Award from Pharmacy Benefit Management Institute® (PBMI) for its Medically Integrated Pharmacy Management (MIPM) approach to achieve better results […]

Read More